Skip to content
Certified ManufacturersFor manufacturers

Nutrition Formulators, Inc.

Miramar, FL, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Nutrition Formulators, Inc. is a dietary supplement manufacturer in Miramar, FL, United States, certified to NSF/ANSI 455-2 GMP, with 3 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, liquids, oils, powders and tablets.

Facilities listed
5
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (3)

  • 3260 Executive Way, Miramar, FL 33025, United States

    • Dry Formulation
    • Encapsulation
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing
  • 10024 Premier Parkway, Miramar, FL 33025, United States

    • Warehousing
  • 10173 USA Today, Miramar, FL 33025, United States

    • Warehousing

Distribution (2)

  • 10173 USA Today, Miramar, FL 33025, United States

    • Warehousing
  • 3320 Executive Way, Miramar, FL 33025, United States

    • Warehousing

How Nutrition Formulators, Inc. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name Nutrition Formulators, Inc. in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 5 food or dietary supplement inspections at facilities matching Nutrition Formulators, Inc., from 2014 to 2025, as of . 1 found no objectionable conditions and 4 found conditions the firm was left to correct.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miramar, Florida

    3 citations posted:

    • Master manufacturing record - record requirements (21 CFR 111.210)
    • Laboratory facilities (21 CFR 111.310)
    • Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))
    Full citation text
    • Master manufacturing record - record requirements (21 CFR 111.210)

      Your master manufacturing record did not include all required information.

    • Laboratory facilities (21 CFR 111.310)

      You did not use adequate laboratory facilities to perform testing and examinations necessary to determine whether your component specifications were met.

    • Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))

      You did not perform manufacturing operations under conditions and controls that protect against the potential for contamination.

    FEI 3003782378

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miramar, Florida

    3 citations posted:

    • Quality control - finished batch, distribution (21 CFR 111.123(a)(8))
    • Quality control - batch, product specifications (21 CFR 111.123(b)(2))
    • Quality control operations - product complaints; investigate (21 CFR 111.135)
    Full citation text
    • Quality control - finished batch, distribution (21 CFR 111.123(a)(8))

      Your quality control operations did not include approving and releasing, or rejecting, each finished batch for distribution.

    • Quality control - batch, product specifications (21 CFR 111.123(b)(2))

      Your quality control personnel approved and released for distribution a batch of dietary supplement that did not meet established product specifications.

    • Quality control operations - product complaints; investigate (21 CFR 111.135)

      Your quality control operations for product complaints did not include reviewing and approving the findings and follow-up action of any investigation performed.

    FEI 3003782378

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miramar, Florida

    4 citations posted:

    • Personnel - quality control operations; responsibilities (21 CFR 111.12(b))
    • Specifications - component identity (21 CFR 111.70(b)(1))
    • Quality control - finished batch, distribution (21 CFR 111.123(a)(8))
    • Packaging description, representative label (21 CFR 111.210(g))
    Full citation text
    • Personnel - quality control operations; responsibilities (21 CFR 111.12(b))

      The personnel you identified to perform quality control operations do not have distinct and separate responsibilities related to performing such operations from those responsibilities that the personnel otherwise have when not performing such operations.

    • Specifications - component identity (21 CFR 111.70(b)(1))

      You did not establish an identity specification for each component.

    • Quality control - finished batch, distribution (21 CFR 111.123(a)(8))

      Your quality control operations did not include approving and releasing, or rejecting, each finished batch for distribution.

    • Packaging description, representative label (21 CFR 111.210(g))

      Your master manufacturing record did not include a representative label, or a cross-reference to the physical location of the actual or representative label.

    FEI 3003782378

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Miramar, Florida

    5 citations posted:

    • Personnel - records - training (21 CFR 111.14(b)(2))
    • Equipment - controls, intended use (21 CFR 111.30(e))
    • Written procedures - quality control operations (21 CFR 111.103)
    • Master manufacturing record - specifications; quality (21 CFR 111.205(b)(1))
    See all 5 citations
    • Personnel - records - training (21 CFR 111.14(b)(2))

      You did not make and keep documentation of training.

    • Equipment - controls, intended use (21 CFR 111.30(e))

      You did not establish and use appropriate controls to ensure that your automated, mechanical, or electronic equipment functions in accordance with its intended use.

    • Written procedures - quality control operations (21 CFR 111.103)

      You did not follow written procedures for quality control operations.

    • Master manufacturing record - specifications; quality (21 CFR 111.205(b)(1))

      Your master manufacturing record did not identify specifications for the points, steps, or stages in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.

    • Batch record - complete (21 CFR 111.255(b))

      Your batch production record did not include complete information relating to the production and control of each batch.

    FEI 3003782378

  • No action indicated · No objectionable conditions found

    Inspected

    Miramar, Florida

    FEI 3003782378

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 5 facility addresses
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026